about
cAMP/PKA signaling balances respiratory activity with mitochondria dependent apoptosis via transcriptional regulation.Mitochondria as a target in treatmentPON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell deathChemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin FluctuationOne enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activityBombesin analogue-mediated delivery preferentially enhances the cytotoxicity of a mitochondria-disrupting peptide in tumor cellsEfficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cellsCracking the cytotoxicity code: apoptotic induction of 10-acetylirciformonin B is mediated through ROS generation and mitochondrial dysfunctionAkt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.SIRT3 and SIRT5 regulate the enzyme activity and cardiolipin binding of very long-chain acyl-CoA dehydrogenase.Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerCellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumorsNegative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapyThe oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilizationMitochondrial permeability transition pore as a selective target for anti-cancer therapyThe mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell linesInorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics.Roles of mitochondria in human disease.The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.Gold nanoparticle-enhanced photodynamic therapy: effects of surface charge and mitochondrial targeting.Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity.MitoTimer: a novel tool for monitoring mitochondrial turnover.Inhibitory effect of chinese propolis on phosphatidylcholine-specific phospholipase C activity in vascular endothelial cells.Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effectsA luminescent cyclometalated iridium(III) complex accumulates in mitochondria and induces mitochondrial shortening by conjugation to specific protein targets.Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells.Mitochondria-targetable carbon quantum dots for differentiating cancerous cells from normal cells.Melatonin Can Strengthen the Effect of Retinoic Acid in HL-60 Cells
P2860
Q27939781-5527F00E-B811-4605-925C-F8ED56FEAF11Q28382780-AA4CAE26-9AB4-40D8-9820-7AA59235C092Q28387637-3F862AB1-22B3-4E1C-830E-6AA34417187CQ28389330-F8C25DB4-4DC6-47EC-9154-2CC74627ADE6Q28397498-35871D91-AB0F-4609-8C90-3197B32E3EC4Q28486692-C0229AD5-DBBD-4B8D-A5EF-5D364280C0CFQ30419657-EEC8D62A-7E62-488F-AC7E-21D8B4AD80B1Q33736781-A6A66906-5E6E-492D-ABC4-D2A0A1800421Q33748081-5F9B6459-437E-4C79-B9DE-7BA7A35183DFQ34768395-B5238170-4285-4931-AB86-8A6B1EB4ABF9Q35168122-9CFA0D7A-5939-4FFB-AA3C-CCEB943C4661Q35220000-238CABC6-5CA9-4C09-9A99-9B1770834E01Q35913045-96E61063-965D-4227-A5C1-9A5590A95D46Q35976820-F9E3F923-C122-4DD4-9504-1A9783FC3B68Q36356176-80FED17D-7D24-43E7-9C20-3478C9886778Q36413553-F50270A5-86E4-484E-8193-31469D479494Q36668047-F8071118-857B-422E-8CDF-8C9F00FEEB2BQ36753310-C1C12A68-8AEE-46E3-A3A7-DEA382072EF9Q37404658-FF570F6E-3809-4B59-9751-D24D17FBCEF0Q37763723-5E602A7D-EB52-40C3-A550-0E04FDA2EE0CQ38198015-B5ABF36F-E02D-4F3C-BE32-ACA9C5C257FEQ38704083-4FB89E0C-D6A4-490D-981C-ED5FA233EB31Q38889799-65BA8038-4776-4CDF-BB9B-91E86DBFA737Q39256612-C630AAB9-597B-45F3-9255-159BCC4D58CDQ39802032-AE539DF8-A727-4FF5-B064-BE7DD7FDC1A6Q42399534-99B12753-B27F-443B-B38E-7B72C40C88F4Q42575787-DF81FCDE-752E-4A58-9F58-308510121E35Q42828784-F8F67FF5-BFC1-473A-A01B-D1F014364856Q46157208-67C3689B-5CD3-4AD3-99EA-E9C63CC91845Q46834583-0BC93B21-DD62-4409-8ECD-F0DFD8F4990DQ47343158-769C62AF-2C82-4ECD-BFD9-4BDE7B90A182Q59133781-030B6B13-2D3C-4CB4-9F5E-38880DF07FC5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitochondria as targets for chemotherapy.
@en
Mitochondria as targets for chemotherapy.
@nl
type
label
Mitochondria as targets for chemotherapy.
@en
Mitochondria as targets for chemotherapy.
@nl
prefLabel
Mitochondria as targets for chemotherapy.
@en
Mitochondria as targets for chemotherapy.
@nl
P2860
P50
P1433
P1476
Mitochondria as targets for chemotherapy.
@en
P2093
Vladimir Gogvadze
P2860
P2888
P304
P356
10.1007/S10495-009-0323-0
P577
2009-04-01T00:00:00Z